Cal Robinson
@kidneycal.bsky.social
SickKids Pediatric Nephrology | PhD student | Toronto 🇨🇦 | Aspiring clinician-scientist | Adaptive clinical trials, target trial emulation, and health admin data research
https://www.researchgate.net/profile/Cal-Robinson-2
https://www.researchgate.net/profile/Cal-Robinson-2
Reposted by Cal Robinson
Comparative Efficacy of Nonsteroid Immunosuppressive Medications in Childhood Nephrotic Syndrome @aspneph @capneph #medsky #nephsky
https://buff.ly/4aC7NNn
https://buff.ly/4aC7NNn
January 27, 2025 at 10:30 PM
Comparative Efficacy of Nonsteroid Immunosuppressive Medications in Childhood Nephrotic Syndrome @aspneph @capneph #medsky #nephsky
https://buff.ly/4aC7NNn
https://buff.ly/4aC7NNn
Excited to share our article today published in JAMA Pediatrics.
Using target trial emulation methods, we found no difference between cyclophosphamide vs calcineurin inhibitors for preventing childhood nephrotic syndrome relapses.
jamanetwork.com/journals/jam...
Using target trial emulation methods, we found no difference between cyclophosphamide vs calcineurin inhibitors for preventing childhood nephrotic syndrome relapses.
jamanetwork.com/journals/jam...
Comparative Efficacy of Nonsteroid Immunosuppressive Medications in Childhood Nephrotic Syndrome
This study evaluates the comparative effectiveness of cyclophosphamide vs calcineurin inhibitors (tacrolimus or cyclosporine) for childhood nephrotic syndrome relapse prevention.
jamanetwork.com
January 27, 2025 at 10:06 PM
Excited to share our article today published in JAMA Pediatrics.
Using target trial emulation methods, we found no difference between cyclophosphamide vs calcineurin inhibitors for preventing childhood nephrotic syndrome relapses.
jamanetwork.com/journals/jam...
Using target trial emulation methods, we found no difference between cyclophosphamide vs calcineurin inhibitors for preventing childhood nephrotic syndrome relapses.
jamanetwork.com/journals/jam...
Half of all children with nephrotic syndrome are diagnosed or treated for hypertension.
Hypertension is more common in those with steroid resistance and frequent relapses.
BP should be monitored regularly in children with nephrotic syndrome!
www.jpeds.com/article/S002...
Hypertension is more common in those with steroid resistance and frequent relapses.
BP should be monitored regularly in children with nephrotic syndrome!
www.jpeds.com/article/S002...
DEFINE_ME
www.jpeds.com
December 24, 2024 at 4:13 PM
Half of all children with nephrotic syndrome are diagnosed or treated for hypertension.
Hypertension is more common in those with steroid resistance and frequent relapses.
BP should be monitored regularly in children with nephrotic syndrome!
www.jpeds.com/article/S002...
Hypertension is more common in those with steroid resistance and frequent relapses.
BP should be monitored regularly in children with nephrotic syndrome!
www.jpeds.com/article/S002...
Less than one-third of children with nephrotic syndrome achieve prolonged remission after cyclophosphamide or tacrolimus. Relapse rate before treatment is the strongest predictor of subsequent relapse.
Read our article published in Pediatric Nephrology: link.springer.com/article/10.1...
Read our article published in Pediatric Nephrology: link.springer.com/article/10.1...
Prolonged remission after cyclophosphamide or tacrolimus treatment in childhood nephrotic syndrome: a cohort study - Pediatric Nephrology
Background Steroid-sparing immunosuppression is used in 50% of children with nephrotic syndrome, to prevent relapses and steroid-related toxicity. However, rates and predictors of prolonged remission ...
link.springer.com
November 22, 2024 at 1:41 PM
Less than one-third of children with nephrotic syndrome achieve prolonged remission after cyclophosphamide or tacrolimus. Relapse rate before treatment is the strongest predictor of subsequent relapse.
Read our article published in Pediatric Nephrology: link.springer.com/article/10.1...
Read our article published in Pediatric Nephrology: link.springer.com/article/10.1...
Central line locking with 4% tetrasodium EDTA decreased CLABSI incidence by 79% in pediatric hemodialysis patients at our center.
Read our article published in Pediatric Nephrology to find out more! link.springer.com/article/10.1...
Read our article published in Pediatric Nephrology to find out more! link.springer.com/article/10.1...
Use of 4% tetrasodium EDTA (KiteLock™) to prevent central venous catheter–related bloodstream infections in pediatric hemodialysis patients - Pediatric Nephrology
Background Central venous catheter (CVC)–related bloodstream infections (CRBSI) are common in children receiving hemodialysis and cause significant morbidity and healthcare costs. Unlike standard lock...
link.springer.com
November 22, 2024 at 1:38 PM
Central line locking with 4% tetrasodium EDTA decreased CLABSI incidence by 79% in pediatric hemodialysis patients at our center.
Read our article published in Pediatric Nephrology to find out more! link.springer.com/article/10.1...
Read our article published in Pediatric Nephrology to find out more! link.springer.com/article/10.1...
Reposted by Cal Robinson
Welcome, #MedSky & #NephSky friends! 🌟 Since many of you are new here, I’m excited to highlight the importance of follow-up care for kids who’ve experienced #AKI - A crucial but underappreciated issue in paediatric nephrology! 🩺 this is a thread! #KidneyHealth #Paediatrics
🔗 1/4
🔗 1/4
November 12, 2024 at 11:35 PM
Welcome, #MedSky & #NephSky friends! 🌟 Since many of you are new here, I’m excited to highlight the importance of follow-up care for kids who’ve experienced #AKI - A crucial but underappreciated issue in paediatric nephrology! 🩺 this is a thread! #KidneyHealth #Paediatrics
🔗 1/4
🔗 1/4